We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
182 hedge funds and large institutions have $401M invested in Fate Therapeutics in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
142% more call options, than puts
Call options by funds: $116K | Put options by funds: $48K
73% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 22
16% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 49
9% more funds holding
Funds holding: 167 → 182 (+15)
16.69% less ownership
Funds ownership: 124.12% → 107.43% (-17%)
56% less capital invested
Capital invested by funds: $904M → $401M (-$503M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
182
Holders Change
+15
Holders Change %
+8.98%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
38
Increased
57
Reduced
49
Closed
22
Calls
$116K
Puts
$48K
Net Calls
+$68K
Net Calls Change
-$1.22M
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$5.98M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$5.94M |
| 3 |
D.E. Shaw & Co
New York
|
+$5.9M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$5.25M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$5.16M |
Top Sellers
| 1 |
SCM
Suvretta Capital Management
New York
|
-$18.8M |
| 2 |
Holocene Advisors
New York
|
-$18.6M |
| 3 |
State Street
Boston,
Massachusetts
|
-$11.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.6M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$6.51M |
